IPR Strategy

It might be surprising that there are not already a large number of companies, which take advantage of the many opportunities there are for the utilization of the green-juice from Cannabis sativa.

There is, of course, a natural and obvious explanation for this: Extracting green-juice – and producing green bio-proteins from Cannabis sativa is by no means simple:

Loss of bioavailability and nutritional value

The proteins in the green-juice begin to degrade and/or cross-link to each other quite shortly after the green-juice has been produced, whereby the protein loses a large part of its bioavailability and, thereby, also a large part of its nutritional value.

Loss of internal plant structure

The green-juice binds to the internal structures of the plant very shortly after the plant is harvested, whereby the green-juice is lost, as it cannot be squeezed out.

The solution

In Prolutica we have solved the two challenges previously mentioned, so we can still get more than 94% of the green-juice out of the harvested hemp plants more than 30 hours after harvest (see the fig. to the left/right), which is a really crucial breakthrough in the utilization of green-juice from Cannabis sativa. As we have very extensive experience in working with proteins and have previously solved similar challenges with degradation and cross-linking, we can today reduce the degradation rate all the way down to approx. 6% for most proteins.

These very large advances are the cornerstones of Prolutica’s IPR-strategy, which covers equipment -, method – and technology development, and extends all the way to IPR protection of individual BANS.

These very large advances are the cornerstones of Prolutica ApS’ IPR strategy, which covers equipment -, method – and technology development, and extends all the way to IPR protection of individual BANS.

Therefore, it is a very broad, sound and strong IPR-strategy.

At the same time, there will be good IPR possibilities for patenting the function of the unknown BANS, when their function and/or possible physiological significance in connection with disease pathogenesis and possibly treatment have been established.

The strength of our intended harvesting -, production – and purification methods mean, among other things, that we in many cases can keep positive synergistic complexes of different BANS together throughout the purification phase. This makes it easier to investigate a possible physiological effect, and here it is a very big advantage for Prolutica that several of the partners in Prolutica have very extensive and international experience in testing new drugs as well as toxicity in studies on primary, human cells and tissues.

Several of the partners in Prolutica have already used such an IPR-strategy in connection with patents for BANS from completely different species, which is why Prolutica already possesses an extensive experience for such an IPR-strategy.

Problem solved!

The biggest problem with production of green-juice is that the juice quickly binds to the plant material after harvest and is, thus, lost (the black curve). We have been working on two different production improvements (the blue and the green curve) – both of which work well. But by combining these methods, you can improve the production so much that even 30 hours after har­vest, it is still possible to squeeze out 94% of the green juice (the red curve). These new methods and equipment are part of Prolu­tica’s IPR.

These improvements will be implemented in the new equipment, which will be produced in 2022.

Source: Prolutica ApS

Prolutica ApS · CVR no. 42268062 · VAT DK42268062 · Valmuemarken 16 · DK-5260 Odense S · Denmark · [email protected]